Advances in Image Guided Cancer Nanomedicine

PRELIMS.pdf
	Preface
	Acknowledgements
	Editor biography
		Lead editor Dr Nanasaheb Thorat, MSc, PhD (Gold Medal), MRSC
	List of contributors
		Outline placeholder
			Professor Niroj Sahu
			Dr Sandeep B Somvanshi
CH001.pdf
	Chapter 1 Introduction to cancer nanomedicine and nanotheranostics
		1.1 Introduction
		1.2 Nanotheranostics and nanomedicine
		1.3 Nanomedicine as contrast agents for localized imaging
		1.4 Nanomedicines for imaging-guided cancer therapy
		1.5 Nanotheranostics in cancer treatments
			1.5.1 Gold nanoparticles
			1.5.2 Magnetic nanoparticles
			1.5.3 Mesoporous silica nanoparticles
			1.5.4 Dendrimers
			1.5.5 Polymeric nanoparticles
		1.6 Nanomedicine interaction with tumor environment and its clearance pathways
		1.7 Clinical status of nanomedicines
		1.8 Conclusion
		References
CH002.pdf
	Chapter 2 Introduction to imaging modalities
		2.1 Introduction
		2.2 Different types of imaging modalities
			Computed tomography
			Magnetic resonance imaging (MRI)
			Ultrasound imaging (US)
			X-ray imaging
			Positron emission tomography (PET)
			Differences between PET, CT and MRI scanning
			2.2.1 Basics and fundamentals of imaging techniques
			Magnetic resonance imaging (MRI)
			Computed tomography (CT)
			Optical imaging (OI)
			Positron emission tomography (PET) and single-photon emission computed tomography (SPECT)
			Photo-acoustic imaging (PAI)
		2.3 Imaging modalities for cancer management
			2.3.1 Diagnostics
			2.3.2 Therapy monitoring
		2.4 Conclusion
		References
CH003.pdf
	Chapter 3 Nanoplatforms for cancer imagining
		3.1 Introduction
		3.2 Nanomedicines for cancer imaging
			3.2.1 Types of nanoplatforms as imaging agents
		3.3 Nanomedicines and radio-imaging techniques
		3.4 Nanomedicines and new generation imaging techniques
		3.5 Conclusions
		Acknowledgments
		References
CH004.pdf
	Chapter 4 Synergy between nanomedicine and tumor imaging
		4.1 Introduction
		4.2 Multifunctional nanoplatforms for cancer diagnosis
		4.3 Nanoplatforms for therapy monitoring using imaging techniques
		4.4 Image-guided nanomedicine animal models and clinical implications
		4.5 Conclusions
		Conflict of interest
		Acknowledgments
		References